An Immune Checkpoint-Related Gene Signature for Predicting Survival of Pediatric Acute Myeloid Leukemia

Figure 3

Signature prediction value in pediatric AML. (a) A heat map showing the three patterns of gene expression linked to immune checkpoint in both the TARGET and GEO categories of high and low risk. (b) The distribution of risk score. (c) Distribution of status in high- and low-risk AML patients. The dot indicates the condition of the patient by the rising risk. The x-axis consists of the number of patients with a y-axis of time of survival. (d) The death rates of all the risk categories. (e), (f) The general survival curves of Kaplan–Meier patients allocated to high- and low-risk groups depending on the median score of the risk score.

(a)

(b)

(c)

(d)

(e)

(f)